Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curi is a U.S. healthcare-focused advisory, insurance, and financial services company serving physicians, healthcare organizations, and their families. Its core business is medical professional liability insurance, complemented by healthcare consulting through Curi Advisory and wealth and asset management through Curi Capital. The company positions itself as a full-service partner spanning medicine, business, and life, with offerings in risk management, clinical and business optimization, and financial planning. Curi operates nationally and was strengthened by its October 1, 2023 merger with Constellation and the subsequent combination of Curi Capital with RMB Capital. It is not a drug-development biotech or pharma company, but it is directly tied to the healthcare sector through provider-focused insurance and advisory services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curi.